Estimating Health Adjusted Age at Death (HAAD)
Open Access
- 14 July 2020
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 15 (7) , e0235955
Abstract
At any point in time, a person’s lifetime health is the number of healthy life years they are expected to experience during their lifetime. In this article we propose an equity-relevant health metric, Health Adjusted Age at Death (HAAD), that facilitates comparison of lifetime health for individuals at the onset of different medical conditions, and allows for the assessment of which patient groups are worse off. A method for estimating HAAD is presented, and we use this method to rank four conditions in six countries according to several criteria of “worse off” as a proof of concept. For individuals with specific conditions HAAD consists of two components: past health (before disease onset) and future expected health (after disease onset). Four conditions (acute myeloid leukemia (AML), acute lymphoid leukemia (ALL), schizophrenia, and epilepsy) are analysed in six countries (Ethiopia, Haiti, China, Mexico, United States and Japan). Data from 2017 for all countries and for all diseases were obtained from the Global Burden of Disease Study database. In order to assess who are the worse off, we focus on four measures: the proportion of affected individuals who are expected to have HAADth and 75th percentiles of HAAD for affected individuals (Q1 and Q3, respectively), and the average HAAD (aHAAD) across all affected individuals. Even in settings where aHAAD is similar for two conditions, other measures may vary. One example is AML (aHAAD = 59.3, T20 = 2.0%, Q3-Q1 = 14.8) and ALL (58.4, T20 = 4.6%, Q3-Q1 = 21.8) in the US. Many illnesses, such as epilepsy, are associated with more lifetime health in high-income settings (Q1 in Japan = 59.2) than in low-income settings (Q1 in Ethiopia = 26.3). Using HAAD we may estimate the distribution of lifetime health of all individuals in a population, and this distribution can be incorporated as an equity consideration in setting priorities for health interventions.Keywords
Funding Information
- Bill and Melinda Gates Foundation (OPP1162384)
This publication has 26 references indexed in Scilit:
- Concerns for severity in priority setting in health care: A review of trade-off data in preference studies and implications for societal willingness to pay for a QALYHealth Policy, 2014
- WHICH CRITERIA ARE CONSIDERED IN HEALTHCARE DECISIONS? INSIGHTS FROM AN INTERNATIONAL SURVEY OF POLICY AND CLINICAL DECISION MAKERSInternational Journal of Technology Assessment in Health Care, 2013
- Lifetime QALY prioritarianism in priority settingJournal of Medical Ethics, 2012
- Incidence, prevalence, and hybrid approaches to calculating disability-adjusted life yearsPopulation Health Metrics, 2012
- Decision-Making Criteria among National Policymakers in Five Countries: A Discrete Choice Experiment Eliciting Relative Preferences for Equity and EfficiencyValue in Health, 2012
- CAN COST-EFFECTIVENESS ANALYSIS INTEGRATE CONCERNS FOR EQUITY? SYSTEMATIC REVIEWInternational Journal of Technology Assessment in Health Care, 2012
- Modeling causes of death: an integrated approach using CODEmPopulation Health Metrics, 2012
- Physical health disparities and mental illness: the scandal of premature mortalityThe British Journal of Psychiatry, 2011
- Balancing equity and efficiency in the Dutch basic benefits package using the principle of proportional shortfallThe European Journal of Health Economics, 2011
- Why It Matters That Some Are Worse Off Than Others: An Argument against the Priority ViewPhilosophy & Public Affairs, 2009